Table 3.
Comparison of visual acuity values at baseline and month 12
| Overall | POAG | NVG | PXG | PG | ACG | AG | PCG/JOAG | SOG | P value | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 118) | (n = 37) | (n = 28) | (n = 15) | (n = 7) | (n = 8) | (n = 11) | (n = 8) | (n = 4) | |||
| Baseline visual acuity ‡ | NLP | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.797** |
| LP– HM | 10 (8.5) | 2 (5.4) | 3 (10.7) | 1 (6.7) | 0 (0.0) | 2 (25.0) | 2 (18.2) | 0 (0.0) | 0 (0.0) | ||
| CF – 20/200 | 76 (64.4) | 25 (67.6) | 19 (67.9) | 9 (60.0) | 3 (42.9) | 5 (62.5) | 6 (54.5) | 6 (75.0) | 3 (75.0) | ||
| ≥ 20/200 | 32 (27.1) | 10 (27.0) | 6 (21.4) | 5 (33.3) | 4 (57.1) | 1 (12.5) | 3 (27.3) | 2 (25.0) | 1 (25.0) | ||
| Visual acuity (Month 12) ‡ | NLP | 1 (0.8) | 0 (0.0) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.383** |
| LP – HM | 10 (8.5) | 2 (5.4) | 3 (10.7) | 0 (0.0) | 0 (0.0) | 3 (37.5) | 2 (18.2) | 0 (0.0) | 0 (0.0) | ||
| CF – 20/200 | 76 (64.4) | 26 (70.3) | 19 (67.9) | 9 (60.0) | 3 (42.9) | 4 (50.0) | 6 (54.5) | 6 (75.0) | 3 (75.0) | ||
| ≥ 20/200 | 31 (26.3) | 9 (24.3) | 6 (21.4) | 5 (33.3) | 4 (57.1) | 1 (12.5) | 3 (27.3) | 2 (25.0) | 1 (25.0) |
POAG: Primary Open-Angle Glaucoma, NVG: Neovascular Glaucoma, PXG: Pseudoexfoliative Glaucoma, PG: Pigmentary Glaucoma, ACG: Angle-Closure Glaucoma, AG: Aphakic Glaucoma, PCG/JOAG: Congenital/Juvenile Glaucoma, SOG: Silicone Oil-Induced Glaucoma, NLP: No perception of light, LP: Light Perception, HM: Hand Motions, CF: Counting Fingers
‡: n (%)
**. Fisher Freeman Halton test
Footnote: Descriptive statistics are presented as numbers and percentages. The Fisher Freeman Halton test was used to compare categorical variables between groups. This test is suitable for small sample sizes and was employed due to the expected frequencies in some cells being less than 5